Lower Newborn Bone Mineral Content Associated With Maternal Use of Tenofovir Disoproxil Fumarate During Pregnancy
George K. Siberry(Columbia University Irving Medical Center), Kenneth Rich(University of Illinois Chicago), Mariam Davtyan(LAC+USC Medical Center), Heidi J. Kalkwarf(Cincinnati Children's Hospital Medical Center), Emily Barr(University at Buffalo, State University of New York), Denise L. Jacobson(Cancer Research And Biostatistics), Katherine M. Knapp(St. Jude Children's Research Hospital), Justin Wheeler(Tufts University), Linda A. DiMeglio(Urology of Indiana), Julia Wu(Harvard University), Lynne Mofenson(Elizabeth Glaser Pediatric AIDS Foundation), Laurie Butler(Frontier Science & Technology Research Foundation, Inc.), Russell B. Van Dyke(Tulane University), Tracie L. Miller(University of Missouri–Kansas City), George R. Seage(Unknown), Rohan Hazra, Ram Yogev(Northwestern University)
Cited by 120
Related Papers
Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIVNET 012 randomised trial
|The Lancet|1999|1.7k
Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 Transmission
|JAIDS Journal of Acquired Immune Deficiency Syndromes|2002|896
Lymphocyte subsets in healthy children from birth through 18 years of age
|Journal of Allergy and Clinical Immunology|2003|828
Maternal Viral Load, Zidovudine Treatment, and the Risk of Transmission of Human Immunodeficiency Virus Type 1 from Mother to Infant
|New England Journal of Medicine|1996|817